Arbutus Biopharma (ABUS) Tax Rate (2015 - 2022)

Arbutus Biopharma (ABUS) posted Tax Rate of 39.25% for Q1 2022, down 395.15% sequentially from 13.3% in Q3 2019.

Arbutus Biopharma (ABUS) Tax Rate (2015 - 2022) Analysis & Trends

Arbutus Biopharma has reported Tax Rate for 6 years, with the latest figure at 39.25% in Q1 2022.

Quarterly Tax Rate changed N/A year-over-year to 39.25% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 6.84% (changed N/A YoY) and the FY2022 annual result came in at 6.84%, changed N/A from the prior year.
Tax Rate eased to 39.25% in Q1 2022 per ABUS's latest filing, from 13.3% in the prior quarter.
Over five years, Tax Rate peaked at 14.89% in Q3 2018 and troughed at 39.25% in Q1 2022.
A 3-year average of 3.69% and a median of 13.3% in 2019 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 159 bps in 2019, down 159 bps in 2019.
Over 3 years, Tax Rate stood at 14.89% in 2018, then decreased by 11 bps to 13.3% in 2019, then plunged by 395 bps to 39.25% in 2022.
According to Business Quant data, Tax Rate over the past three periods registered 39.25%, 13.3%, and 14.89% for Q1 2022, Q3 2019, and Q3 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Arbutus Biopharma	922.95 Mn	830.33 Mn	-	-

Download Data